Credit Suisse Ag Relay Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 82,750 shares of RLAY stock, worth $738,957. This represents 0.0% of its overall portfolio holdings.

Number of Shares

82,750

Previous 82,750 -0.0%

Holding current value

$738,957

Previous $911,000 24.7%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$6.01 - $11.48 $37,538 - $71,704	-6,246 Reduced 7.02%	82,750 $911,000
Q3 2023 Nov 13, 2023	SELL	$8.24 - $12.97 $243,681 - $383,561	-29,573 Reduced 24.94%	88,996 $748,000
Q2 2023 Aug 11, 2023	BUY	$9.99 - $18.27 $370,698 - $677,944	37,107 Added 45.55%	118,569 $1.49 Million
Q1 2023 May 10, 2023	BUY	$15.0 - $22.76 $80,190 - $121,674	5,346 Added 7.02%	81,462 $1.34 Million
Q4 2022 Feb 13, 2023	BUY	$14.16 - $24.02 $164,369 - $278,824	11,608 Added 17.99%	76,116 $1.14 Million

Q3 2022 Nov 10, 2022	BUY	$18.07 - $31.37 $117,400 - $203,810	6,497 Added 11.2%	64,508 $1.44 Million
Q2 2022 Aug 12, 2022	BUY	$13.31 - $34.88 $333,189 - $873,151	25,033 Added 75.91%	58,011 $971,000
Q1 2022 May 16, 2022	BUY	$20.26 - $32.36 $55,917 - $89,313	2,760 Added 9.13%	32,978 $987,000
Q4 2021 Feb 14, 2022	SELL	$26.0 - $37.03 $68,718 - $97,870	-2,643 Reduced 8.04%	30,218 $928,000
Q3 2021 Nov 12, 2021	SELL	$29.75 - $37.99 $28,976 - $37,002	-974 Reduced 2.88%	32,861 $1.04 Million
Q2 2021 Aug 16, 2021	BUY	$27.5 - $38.19 $124,327 - $172,656	4,521 Added 15.42%	33,835 $1.24 Million
Q1 2021 May 14, 2021	SELL	$32.52 - $61.53 $712,480 - $1.35 Million	-21,909 Reduced 42.77%	29,314 $1.01 Million
Q4 2020 Feb 12, 2021	BUY	$35.51 - $54.03 $1.82 Million - $2.77 Million	51,223 New	51,223 $2.13 Million

Others Institutions Holding RLAY

# of Institutions

190

Shares Held

127M

Call Options Held

4.2K

Put Options Held

1.7K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $1.07B
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account